高脂血症急性胰腺炎的研究进展

Abstract
Figure/Table
References (40)
Related Citation (15)

Download: PDF (0 KB) HTML (50 KB)
Export: BibTeX | EndNote (RIS)

Abstract With the improvement of people′s living standards and changes in dietary patterns,the incidence of hyperlipidemia acute pancreatitis (HLAP)continues to rise.It has the characteristics of younger,more severe,easy to relapse,and atypical symptoms,and there are no relevant guidelines for HLAP to guide the treatment of HLAP,so HLAP is attracting more and more attention.In this paper,we summarize the research on HLAP at home and abroad in terms of etiology,pathogenesis and treatment,and conclude that hyperlipidemia is the key predisposing factor of HLAP,and the pathogenesis is mainly related to free fatty acid damage,microcirculatory disorders,inflammatory response,calcium overload and oxidative stress and so on.However,the lack of a clear treatment plan and the severity of the disease make the treatment difficult.Therefore,the latest research on HLAP in recent years is discussed in order to provide reference for the clinical treatment of HLAP.

Key words： Acute pancreatitis Hyperlipidemia Mechanism Treatment

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GUO Ling-long
	LI Juan-juan
	LI Jing-wei
	JIANG Xiao-yan
	ZHANG Chun-hong
	HUANG Bin

Cite this article:

GUO Ling-long,LI Juan-juan,LI Jing-wei, et al. Research progress of hyperlipidemia acute pancreatitis[J]. 中国当代医药, 2021, 28(32): 28-32.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I32/28

[7]	赵成思，姚维杰，王佐正.高三酰甘油血症性急性胰腺炎治疗进展[J].临床肝胆病杂志，2020，36（12）：2860-2864.
[15]	Khatua B，El-Kurdi B，Singh VP.Obesity and pancreatitis[J].Curr Opin Gastroenterol，2017，33（5）：374-382.
[17]	肖健雄，武依娜，谢东辉.高脂血症性急性胰腺炎的发病机制及治疗的研究进展[J].牡丹江医学院学报，2021，42（1）：158-160.
[18]	Sah RP，Saluja A.Molecular mechanisms of pancreatic injury[J].Curr Opin Gastroenterol，2011，27（5）：444-451.
[19]	Pérez S，Pereda J，Sabater L，et al.Redox signaling in acute pancreatitis[J].Redox Biol，2015，5：1-14.
[1]	杜奕奇，陈其奎，李宏宇，等.中国急性胰腺炎诊治指南（2019 年，沈阳）[J].临床肝胆病杂志，2019，35（12）：2706-2711.
[3]	Garg R，Rustagi T.Management of Hypertriglyceridemia Induced Acute Pancreatitis[J].Biomed Res Int，2018，2018：1-12.
[5]	杨帆，程黎娜，张玲娟，等.清胰汤联合生长抑素对高脂血症性胰腺炎患者胃肠与凝血功能及免疫系统影响[J].世界中西医结合杂志，2019，14（7）：954-957.
[6]	冯萍萍，徐燕芳，童宝燕，等.柴芍承气汤对不同时期高脂血症性急性胰腺炎患者淀粉酶、血脂及炎性因子的影响[J].中国中医药科技，2020，27（1）：15-18.
[2]	Zhu Y，Pan X，Zeng H，et al.A Study on the Etiology，Severity，and Mortality of 3260 Patients With Acute Pancreatitis According to the Revised Atlanta Classification in Jiangxi，China Over an 8-Year Period[J].Pancreas，2017，46（4）：504-509.
[4]	Liu G，Liu F，Xiao L，et al.Narrative review of the mechanisms of action of dachengqi decoction in the treatment of hyperlipidemic pancreatitis on six-hollow-organs to be unblocked theory[J].Ann Palliat Med，2020，9（4）：2323-2329.
[9]	Adiamah A，Psaltis E，Crook M，et al.A systematic review of the epidemiology，pathophysiology and current management of hyperlipidaemic pancreatitis[J].Clin Nutr，2018，37（6）：1810-1822.
[10]	Hahn SJ，Park J，Lee JH，et al.Severe Hypertriglyceridemia in Diabetic Ketoacidosis Accompanied by Acute Pancreati-tis：Case Report[J].J Korean Med Sci，2010，25（9）：1375.
[11]	Inayat F，Zafar F，Riaz I，et al.Hypertriglyceridemic Pancreatitis：Is Insulin Monotherapy A Feasible Therapeutic Option?[J].Cureus，2018，10（10）：e3461.
[12]	Wang Y，Sternfeld L，Yang F，et al.Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells[J].Gut，2009，58（3）：422-430.
[13]	Wang SH，Chou YC，Shangkuan WC，et al.Relationship between Plasma Triglyceride Level and Severity of Hypertriglyceridemic Pancreatitis[J].PLoS One，2016，11（10）：e163984.
[14]	Yan M，Li Y，Meng M，et al.Long-term high-fat diet induces pancreatic injuries via pancreatic microcirculatory disturbances and oxidative stress in rats with hyperlipidemia[J].Biochem Biophys Res Commun，2006，347（1）：192-199.
[20]	Czakó L，Szabolcs A，Vajda A，et al.Hyperlipidemia induced by a cholesterol-rich diet aggravates necrotizing pancreatitis in rats[J].Eur J Pharmacol，2007，572（1）：74-81.
[21]	Zhou ZG，Chen YQ，Liu XB，et al.Changes of cytosolic[Ca2+]i in neutrophils in pancreatic microcirculation of rats with caerulein-induced acute pancreatitis under fluid shear stress[J].World J Gastroenterol，2004，10（21）：3185-3187.
[22]	Jiang J，Wang Y，Ling Y，et al.A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis[J].Lipids Health Dis，2016，15（1）：12.
[23]	Talukdar R，Sareen A，Zhu H，et al.Release of Cathepsin B in Cytosol Causes Cell Death in Acute Pancreatitis[J].Gastroenterology，2016，151（4）：747-758.
[24]	DiMagno MJ，Dimagno EP.Pancreas divisum does not cause pancreatitis，but associates with CFTR mutations[J].Am J Gastroenterol，2012，107（2）：318-320.
[25]	Scherer J，Singh VP，Pitchumoni CS，et al.Issues in Hypertriglyceridemic Pancreatitis：An Update[J].J Clin Gastroenterol，2014，48（3）：195-203.
[26]	Staels B，Dallongeville J，Auwerx J，et al.Mechanism of action of fibrates on lipid and lipoprotein metabolism[J].Circulation，1998，98（19）：2088-2093.
[27]	Ewald N，Hardt PD，Kloer HU.Severe hypertriglyceridemia and pancreatitis：presentation and management[J].Curr Opin Lipidol，2009，20（6）：497-504.
[28]	Khan R，Jehangir W，Regeti K，et al.Hypertriglyceridemia-Induced Pancreatitis：Choice of Treatment[J].Gastroenterology Res，2015，8（3-4）：234-236.
[29]	Kuchay MS，Farooqui KJ，Bano T，et al.Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis：case series and literature review[J].Arch Endocrinol Metab，2017，61（2）：198-201.
[30]	Korn ED.Clearing factor，a heparin-activated lipoprotein lipase Ⅱ Substrate specificity and activation of coconutoil[J].J Biol Chem，1955，215（1）：15-26.
[31]	Navina S，Acharya C，Delany JP，et al.Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity[J].Sci Transl Med，2011，3（107）：107r-110r.
[32]	马江辰，保志军.高脂血症性急性胰腺炎（HLAP）的治疗进展[J].复旦学报（医学版），2019，46（4）：540-543.
[33]	He WH，Yu M，Zhu Y，et al.Emergent Triglyceride-lowering Therapy With Early High-volume Hemofiltration A-gainst Low-Molecular-Weight Heparin Combined With Insulin in Hypertriglyceridemic Pancreatitis：A Prospective Randomized Controlled Trial[J].J Clin Gastroenterol，2016，50（9）：772-778.
[34]	谭黄业，樊献军，耿协强，等.高脂血症性重症急性胰腺炎临床特征及诊治[J].中华实用诊断与治疗杂志，2010，24（11）：1123-1124.
[35]	Sun S，He L，Bai M，et al.High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis：a controlled pilot study[J].Ann Saudi Med，2015，35（5）：352-358.
[36]	李刚，张素巧，练睿，等.前列地尔治疗高脂血症性重症急性胰腺炎的临床价值[J].中华胰腺病杂志，2017，17（5）：298-301.
[37]	叶丹，柯丽，张川，等.奥曲肽联合前列地尔治疗高脂血症性急性胰腺炎疗效及对患者胃肠功能恢复血淀粉酶阴转率的影响[J].河北医学，2019，25（12）：1975-1978.
[38]	孙文杰，陈亚峰，高磊，等.中药治疗急性胰腺炎机制的研究进展[J].中成药，2019，41（8）：1932-1935.
[39]	付娟，李志.中医特色外治法辅助治疗急性胰腺炎的研究进展[J].西南军医，2020，22（4）：334-337.
[8]	Shah AS，Wilson DP.Primary hypertriglyceridemia in children and adolescents[J].J Clin Lipidol，2015，9（5 Suppl）：S20-S28.
[40]	阿依江·加马力丁，王军红，马青变.重症急性胰腺炎肠道菌群变化的研究进展[J].中国急救医学，2021，41（5）：454-457.